A systematic review of efficacy and tolerability of mebeverine in irritable bowel syndrome.

World Journal of Gastroenterology : WJG
Mahnaz Darvish-DamavandiMohammad Abdollahi

Abstract

We evaluated the efficacy and tolerability of mebeverine, a musculotropic antispasmodic agent, in irritable bowel syndrome (IBS) and compared its usual dosages by meta-analysis. Medical databases and all relevant literature were searched from 1965 to June 2009 for any placebo-controlled clinical trials of mebeverine, using search terms such as mebeverine, clinical trials, and IBS. Eight randomized trials met our criteria, including six trials that compared mebeverine with placebo and two that compared mebeverine tablets with capsules. These eight trials included 555 patients randomized to receive either mebeverine or placebo with 352 (63%) women and 203 (37%) men in all subtypes of IBS. The pooled relative risk (RR) for clinical improvement of mebeverine was 1.13 (95% CI: 0.59-2.16, P = 0.7056) and 1.33 (95% CI: 0.92-1.93, P = 0.129) for relief of abdominal pain. The efficacy of mebeverine 200 mg compared to mebeverine 135 mg indicated RRs of 1.12 (95% CI: 0.96-1.3, P = 0.168) for clinical or global improvement and 1.08 (95% CI: 0.87-1.34, P = 0.463) for relief of abdominal pain. Thus, mebeverine is mostly well tolerated with no significant adverse effects; however, its efficacy in global improvement of IBS is not statistically...Continue Reading

References

Feb 1, 1972·Australian and New Zealand Journal of Medicine·P Baume
Nov 15, 1980·British Medical Journal·J A Ritchie, S C Truelove
Jan 1, 1980·Current Medical Research and Opinion·K Lüttecke
Oct 7, 2000·Journal of Gastroenterology and Hepatology·C L LuS D Lee
Mar 19, 2003·Alimentary Pharmacology & Therapeutics·A P S HunginF Mearin
May 27, 2005·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·S M PatelA J Lembo
Aug 27, 2005·Deutsche medizinische Wochenschrift·P EnckW Kruis
May 10, 2008·Diseases of the Colon and Rectum·Shekoufeh NikfarMohammad Abdollahi
Apr 3, 2009·World Journal of Gastroenterology : WJG·Roja RahimiMohammad Abdollahi

❮ Previous
Next ❯

Citations

Dec 25, 2012·Chinese Journal of Integrative Medicine·Azar Asadi-ShahmirzadiMohammad Abdollahi
Oct 5, 2010·Nature Reviews. Gastroenterology & Hepatology·Sarah Khan, Lin Chang
Nov 18, 2011·World Journal of Gastroenterology : WJG·Pooneh Salari, Mohammad Abdollahi
Mar 1, 2012·World Journal of Gastroenterology : WJG·Roja Rahimi, Mohammad Abdollahi
Oct 5, 2011·Pharmacognosy Magazine·Shilan MozaffariMohammad Abdollahi
May 31, 2014·World Journal of Gastroenterology : WJG·Bhupinder Kaur Sandhu, Siba Prosad Paul
May 31, 2014·World Journal of Gastroenterology : WJG·Anita AnnaháziTibor Wittmann
Dec 8, 2011·Journal of Neurogastroenterology and Motility·Full-Young ChangHsiu-Ju Chang
Apr 24, 2012·Journal of Neurogastroenterology and Motility·Bong Ki ChaSae Kyung Chang
Feb 11, 2012·Journal of Neurogastroenterology and Motility·Full-Young Chang
Nov 8, 2013·Journal of Neurogastroenterology and Motility·A Young SeoDong Hyun Oh
Jun 20, 2014·Paediatric Drugs·Adrian Miranda, Miguel Saps
Mar 11, 2011·European Journal of Gastroenterology & Hepatology·Paul EnckUte Martens
Aug 18, 2012·Expert Opinion on Biological Therapy·Asieh HosseiniMohammad Abdollahi
Jan 22, 2013·Expert Opinion on Drug Metabolism & Toxicology·Shilan MozaffariMohammad Abdollahi
Feb 22, 2011·Gastroenterology Clinics of North America·Richard J Saad
Apr 15, 2011·Alimentary Pharmacology & Therapeutics·M Schmulson, L Chang
Sep 17, 2011·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·K J LeeP L Rhee
Jan 18, 2014·Alimentary Pharmacology & Therapeutics·P Layer, V Stanghellini
Aug 5, 2014·BioMed Research International·Zahra PourmoghaddasAli Gholamrezaei
Sep 4, 2014·Asian Pacific Journal of Tropical Biomedicine·Surya Prakash MishraBajrang Lal Pandey
Dec 3, 2014·The Journal of Pediatrics·Judith J KorterinkMerit M Tabbers
Feb 11, 2015·Nature Reviews. Gastroenterology & Hepatology·Judith KorterinkMarc A Benninga
May 8, 2015·Therapeutic Advances in Gastroenterology·Yang Won Min, Poong-Lyul Rhee
Apr 3, 2018·Journal of Neurogastroenterology and Motility·Kyung Ho SongUNKNOWN Clinical Practice Guidelines Group Under the Korean Society of Neurogastroenterology and Motility
Dec 11, 2019·Minerva gastroenterologica e dietologica·Imke MasuyJan Tack
Oct 5, 2017·Prion·Pardis Tabaee DamavandiRichard W Pickersgill
Mar 6, 2015·World Journal of Gastroenterology : WJG·Chun-Yan Li, Shu-Chuen Li
May 10, 2020·Expert Opinion on Drug Metabolism & Toxicology·Taraneh MousaviMohammad Abdollahi
Jan 8, 2018·Psychotherapy and Psychosomatics·Peter HenningsenFrancis Creed
Nov 20, 2019·Journal of Family Medicine and Primary Care·Dwaipayan Sarathi ChakrabortyShantasil Pain
Mar 2, 2021·Saudi Journal of Gastroenterology : Official Journal of the Saudi Gastroenterology Association·Ramesh R Rai, Sandeep Nijhawan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.